✦ LIBER ✦

Bisphosphonates in Multiple Myeloma: Preclinical and Clinical Data

✍ Scribed by Giuliani, Nicola; Dalla Palma, Benedetta; Bolzoni, Marina

Book ID: 121604703
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 317 KB
Volume: 11
Category: Article
ISSN: 1534-8644
DOI: 10.1007/s12018-013-9143-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bisphosphonates in multiple myeloma

✍ John A. Kanis; Eugene V. McCloskey 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views

Bisphosphonates in multiple myeloma

✍ James R. Berenson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

bone destruction resulting in osteolytic lesions, osteoporosis, and pathologic frac-West Los Angeles Veterans Affairs Medical Centures in most patients as well as hypercalcemia and spinal cord compression in ter and the Jonsson Comprehensive Cancer many individuals. These patients frequently require

Bisphosphonates in early multiple myelom

Bisphosphonates in early multiple myeloma

✍ Orhan Sezer; Christian Jakob; Ivana Zavrski; Ulrike Heider; Claudia Fleissner; M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Bisphosphonates in Medical Practice || M

Bisphosphonates in Medical Practice || Multiple Myeloma

✍ Bartl, Reiner; Frisch, Bertha; von Tresckow, Emmo; Bartl, Christoph 📂 Article 📅 2007 🏛 Springer Berlin Heidelberg ⚖ 341 KB

Preclinical data and early clinical expe

Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma

✍ Richardson, Paul G.; Mitsiades, Constantine S.; Laubach, Jacob P.; Hajek, Roman; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 616 KB

The role of bisphosphonates in multiple

The role of bisphosphonates in multiple myeloma

✍ Jessica Levy; G. David Roodman 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 258 KB